NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Twitter Inc. (now X) Shareholders Win $44 Billion Defamation Case Against Elon Musk

Key Findings:

  • A San Francisco jury found Elon Musk, CEO of Tesla Inc., liable for misleading Twitter Inc. (now X) shareholders in 2022.
  • The jury concluded that Musk's tweets about fake accounts on Twitter negatively impacted the company's stock price, leading to a $44 billion offer to acquire Twitter being fulfilled at the original agreed price of $54.20 per share.
  • The verdict may cost Musk billions of dollars, with the final amount to be determined in a later claim process, potentially reaching $2.6 billion.

Background:

Read also: Kumar Mangalam Birla to Address Concluding Function of RSS Training Camp

  • In May 2022, Musk tweeted concerns about the prevalence of fake accounts on Twitter, which led to a decline in the company's stock price.
  • Musk's legal team has vowed to appeal the verdict, citing a "bizarre and highly questionable" joke made by the jury in a verdict form, highlighting the number $4.20, which is cultural slang for pot smoking.

SEC History:

  • In 2018, Musk tweeted "funding secured" to take Tesla Inc. private at $420 a share, leading to a stock price increase, but later abandoning the plan, resulting in a combined $40 million settlement with the SEC.

Investor Response:

Read also: The Cost of Healthcare: Why Predictability in Medical Inflation is Crucial for Health Insurance

  • Lawyers for the investors who brought the case have urged the court to strike Musk's lawyer's letter from the record, calling it "egregiously unfaithful to the record in this case."

Investor Takeaway

Investors should be cautious of potential appeals in the Twitter-Musk case.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.